December 2023

GSK CEO Emma Walmsley expressed optimism about the success of the respiratory syncytial virus (RSV) vaccine, Arexvy, anticipating sales surpassing a billion pounds in its debut year. Despite ongoing costly litigation over the discontinued drug Zantac, Walmsley affirmed that the legal expenses wouldn’t disrupt the company’s capital plans. The vaccine, Arexvy, granted approval by the […]

Novo Nordisk initiated legal action against compounding pharmacies, alleging impurities in their versions of the weight-loss drug Wegovy. The Danish pharmaceutical company refiled a lawsuit against one and sued another after discovering impurities, some samples containing 33% impurity. Wells Pharmacy and Brooksville Pharmaceuticals, both Florida-based, faced allegations of impure formulations containing semaglutide, Wegovy’s active ingredient. […]